Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) is now available.
Jubilant Pharmova Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2025. The results, approved by the Board of Directors, were prepared in compliance with Indian Accounting Standards and SEBI regulations. The review by independent auditors concluded that the financial statements were presented fairly without any material misstatements, indicating stable financial management and compliance with regulatory standards.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products. The company is engaged in providing solutions across the pharmaceutical value chain, including active pharmaceutical ingredients, generics, and specialty pharmaceuticals, catering to a global market.
Average Trading Volume: 8,283
Technical Sentiment Signal: Buy
Current Market Cap: 178.3B INR
For an in-depth examination of JUBLPHARMA stock, go to TipRanks’ Overview page.